Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

145.55 -3.32 (-2.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗
Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes. 
Via MarketBeat
Topics Artificial Intelligence Bonds
News headline image
If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.) ↗
Moderna shares have soared, sunk, and soared again. You might want to consider them. 
Via The Motley Fool
News headline image
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run? ↗
The vaccine maker is making an increasingly robust case that it isn't just a pandemic stock. 
Via The Motley Fool
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
3 Inflated Stocks with Open Questions
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
News headline image
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? ↗
Both have attracted considerable attention from Wall Street recently. 
Via The Motley Fool
News headline image
Why Moderna (MRNA) Stock Is Down Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker dow... 
Via StockStory
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
3 Stocks Whose Competitive Walls Tower Over Nvidia's ↗
A solid moat favors revenue growth, and that's good news for investors. 
Via The Motley Fool
Topics Artificial Intelligence
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Is BioNTech Stock a No-Brainer Buy on the Dip? ↗
The company is coming back into the spotlight thanks to recent developments. 
Via The Motley Fool
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
News headline image
Moderna Stock Moves Lower Wednesday: What's Going On? ↗
Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month. 
Via Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Moderna Stock Climbs Tuesday: What's Going On? ↗
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need to know. 
Via Benzinga
News headline image
Moderna to Present at Upcoming Conferences in September 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell? ↗
The company may be on track to its next product. 
Via The Motley Fool
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
Is It Too Late to Buy Moderna Stock After Its 127% Surge? ↗
Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in. 
Via The Motley Fool
News headline image
VOO vs. RSP: If AI Stocks Get Too Concentrated, Here's Which One I'd Choose ↗
These ETFs both hold S&P 500 members but with very different allocations. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f... 
Via StockStory
Topics Artificial Intelligence
News headline image
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
From Moderna, Inc.
Via ACCESS Newswire
What's going on in today's session: S&P500 movers ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.